| Application no. and date | 04768376.8 (espacenet) (Federated) (European Patent Register), 20040908 | | Patent/reg. no. and date | DK/EP 1663989, 20090415 | | Publication date | 20060607 | | Priority no. and date | GB 0321127, 20030910, GB 0404859, 20040304 | | EP pub. no. and date |
EP 1663989 20060607 | | Effective date | | | Applicant/owner | Astrazeneca UK Limited, 15 Stanhope Gate
London,
Greater London W1K 1LN, GB | | Applicant ref. no. | AST 101183-1X | | Inventor | BOOTH, Rebecca, Jane
AstraZeneca
Charter Way, Macclesfield
Cheshire SK10 2NA, GB,
CITTERN, Peter, Anthony
AstraZeneca
Avlon Works, Severn Road
Hallen
Bristol, Avon BS10 7ZE, GB,
CRABB, Jeffrey, Norman
AstraZeneca
Avlon Works, Severn Road
Hallen
Bristol, Avon BS10 7ZE, GB,
HORBURY, John
AstraZeneca
Avlon Works, Severn Road
Hallen
Bristol, Avon BS10 7ZE, GB,
JONES, David, Wyn, Calvert
AstraZeneca, Avlon Works
Severn Road
Hallen
Bristol, Avon BS10 7ZE, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 3/06 (2006.01) , C07D 239/42 (2006.01) | | Title | Krystallisk form af bis(E)-7-[4(4-fluorphenyl)-6-isopropyl-2-methyl(methylsulfonyl)aminopyrimidin-5-yl(3R,5S))-3-5-dihydroxyhept-6-ensyrecalciumsalt | | Int. application no. | GB2004003829 | | Int. publication no. | WO2005023779 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
